BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hong Kong

Immuno Cure and PharmaJet Partner on Needle-Free HIV Therapeutic Vaccine Study in Hong Kong

Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboratio...

June 20, 2025 | News

VivaVision Receives Positive FDA Feedback on VVN461LD Phase 2 Trial for Ocular Inflammation

VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today t...

June 10, 2025 | News

GenEditBio Doses First Patient in World's First In Vivo CRISPR Trial for TGFBI Corneal Dystrophy

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions through the discovery o...

June 09, 2025 | News

Akeso’s Cadonilimab Secures NMPA Approval for First-Line Treatment of Cervical Cancer

Akeso, Inc. is pleased to announce that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecif...

June 05, 2025 | News

Excyte Doses First Patient in Global Trial of YK012, the First T Cell Engager for Primary Membranous Nephropathy

Excyte, a global clinical-stage biotechnology company, announced first patient has been dosed for YK012, the world’s first patient T cell engager tha...

June 03, 2025 | News

Concord Healthcare Unveils China’s First Proton Therapy-Focused Large Language Model

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), whic...

June 02, 2025 | News

Hong Kong Strengthens Position as Global Healthcare Investment Hub with Over 1,000 Business Meetings at ASGH and Medical Fair

Over 1,000 investment and business matching meetings lined up underscoring Hong Kong's role as a healthcare investment hub - ASGH brought toget...

May 29, 2025 | News

United Imaging and HKSH Medical Group Unite to Set New Standards in Medical Imaging Excellence

United Imaging and HKSH Medical Group announced on Monday the signing of a Memorandum of Understanding (MOU), marking a significant step forward in fosteri...

May 28, 2025 | News

HKSH Medical Group Strengthens Global Healthcare Partnerships with New Collaboration on Imaging Innovation

The HKSH Medical Group (HKSH) has for over a century been committed to acquiring the state-of-the-art, world-class technology and facilities to deliver exc...

May 28, 2025 | News

Antengene and MSD Enter Global Clinical Collaboration to Evaluate ATG-022 and KEYTRUDA® Combo in Solid Tumors

Antengene Corporation Limited , a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercial...

May 21, 2025 | News

AIM Vaccine Secures PRC Clinical Approval for mRNA Shingles Vaccine, Strengthening Global Race in Next-Gen Immunization

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660....

May 20, 2025 | News

Viva Biotech Unveils Advanced AI-Driven Drug Discovery Platform, Pioneering a New Era of Intelligent Therapeutics

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neur...

May 16, 2025 | News

China Grants Full Approval to Everest Medicines’ NEFECON® as First and Only Etiological Treatment for IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

May 07, 2025 | Regulatory

Everest Medicines Secures Hong Kong Approval for VELSIPITY® in Ulcerative Colitis

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeu...

April 30, 2025 | News

Stay Connected